Vascular access for hemodialysis can be provided by a native arteriovenous fistula (AVF), a synthetic arteriovenous graft (AVG), or a central venous catheter. The mature, native fistula is considered the preferred type of vascular access. This study evaluates the results of a retrospective registry assessing topically applied heparin (added to antiplatelet therapy) efficacy in patients with newly created AVF.
Patency of arteriovenous fistula for dialysis improbe with topical spraygel heparin / S. Stuard, G. Belcaro, M. Dugall, M.R. Cesarone, M. Hosoi, B.M. Errichi, E. Ippolito, P. Bavera, U. Cornelli. - In: PANMINERVA MEDICA. - ISSN 0031-0808. - 52:2 Suppl 1(2010 Jun), pp. 33-36.
Patency of arteriovenous fistula for dialysis improbe with topical spraygel heparin
E. Ippolito;
2010
Abstract
Vascular access for hemodialysis can be provided by a native arteriovenous fistula (AVF), a synthetic arteriovenous graft (AVG), or a central venous catheter. The mature, native fistula is considered the preferred type of vascular access. This study evaluates the results of a retrospective registry assessing topically applied heparin (added to antiplatelet therapy) efficacy in patients with newly created AVF.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
